Page 21 - PharmBio2122_25June21
P. 21

                                                                                                                                                                                                                                          SINGAPORE PHARMBIO GUIDE 2021/2022
                                                                                                                                                                                                                   Derrick Tan W. M., Ph.D.
Managing Consultant 1st Phase Operations
Marvin Ng,
MBA, BSc (Microbiology)
Principal Consultant DN Venture Partners
he Singapore Biotech Guide has been published annually since 2002 as a resource for the local biomedical sciences industry. It was renamed the Singapore PharmBio Guide in 2018 to highlight its expanded coverage and role to serve both the biomedical research and manufacturing communities. It now provides up-to-date operational information to pharma, biopharma, and biotech organisations that are planning to set up a commercial, R&D or manufacturing operation in Singapore.
Medical technology firms as well as chemical and chemical engineering companies have also found portions of the guide to be useful. However, we would like to stress that this guide has not been written with this latter group in mind and there may be other operational considerations, such as additional authority clearance and regulatory permit applications, which these companies may need to complete prior to starting up their operations.
The Guide will continue to list the contact information of relevant government agencies and companies that you may call upon for additional information. Information included here is by no means exhaustive and we welcome suggestions of additional topics that may be of interests to readers for inclusion in subsequent editions. This can be done easily by sending us an email at
Happy Reading!
 Derrick Tan
founded 1st Phase Operations in
2002 to provide a one-stop operations consultancy service in business planning and admin / facility startups to pharma, biotech and specialty chemical companies establishing or expanding their operations in Asia. Graduated with a Ph.D. degree in Chemistry (Biological Chemistry), he has since helped more than 100 companies and institutions with their operational needs.
Marvin Ng
has been involved in the public and private life sciences sectors since early 2000 and has assisted companies with their critical business development needs. He is concurrently the director of DN Venture Partners, a life sciences business development consulting firm, and Greener Grass Communications, a public relations firm that focuses on the technology industries.

   19   20   21   22   23